HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Pharmacovigilance
  • >PSUR
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • BREXIT
    • Procedural Guidance
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
      • General Information
      • Referrals
      • PSUR
        • PSUR Single Assessment
        • PSUR Work Sharing and Synchronisation Project
        • Outcome of informal PSUR worksharing procedures
      • RMP
    • Falsified Medicines
    • IGDRP
    • Questions & Answers
    • Contact Points
    • What's new history
  • MRI Product Index
  • Pharmacovigilance
  • Publications and reports
  • National Contacts

Periodic safety update reports

           

  • Best Practice Guide on (1) Introduction of substances/combinations onto the EURD list and setting the initial PSUR DLP and frequency and (2) Assessment of PSURs of products where the EU Reference Date is not yet legally binding (March 2017)
  • Template - PSUR Assessment Report
  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - http://www.hma.eu/314.html